Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1745-6215
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial ; volume:18 ; number:1 ; day:15 ; month:6 ; year:2017 ; pages:1-11 ; date:12.2017
Trials ; 18, Heft 1 (15.6.2017), 1-11, 12.2017
- Schlagwort
-
Hautkrankheit
Dermatologie
- Urheber
-
Saunders, Peter
- Beteiligte Personen und Organisationen
-
Tsipouri, Vicky
Keir, Gregory J.
Ashby, Deborah
Flather, Marcus D.
Parfrey, Helen
Babalis, Daphne
Renzoni, Elisabetta A.
Denton, Christopher P.
Wells, Athol U.
Maher, Toby M.
SpringerLink (Online service)
- DOI
-
10.1186/s13063-017-2016-2
- URN
-
urn:nbn:de:1111-201710139335
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.07.20252025, 11:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Saunders, Peter
- Tsipouri, Vicky
- Keir, Gregory J.
- Ashby, Deborah
- Flather, Marcus D.
- Parfrey, Helen
- Babalis, Daphne
- Renzoni, Elisabetta A.
- Denton, Christopher P.
- Wells, Athol U.
- Maher, Toby M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Connective tissue disease-associated lung disease in children
Mycophenolate mofetil versus cyclophosphamide plus in patients with connective tissue disease-associated interstitial lung disease: Efficacy and safety analysis
Study of connective tissue disease-associated pulmonary hypertension
Learnings from clinical trials in patients with connective tissue disease-associated interstitial lung disease
Vascular endothelial growth factor in hypersensitivity pneumonitis and connective tissue disease-associated interstitial lung disease
Correction: Learnings from clinical trials in patients with connective tissue disease‑associated interstitial lung disease
Quantitative evaluation of disease severity in connective tissue disease-associated interstitial lung disease by dual-energy computed tomography
Can transbronchial lung cryobiopsy benefit adaptive treatment strategies in connective tissue disease-associated interstitial lung disease?
Azathioprine in connective tissue disease-associated interstitial lung disease : data from a retrospective single centre study
Usefulness of lung ultrasound B-lines in connective tissue disease-associated interstitial lung disease: a literature review
Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study
Autoimmune Disease-Associated Hypertension
Connective tissue disease-associated lung disease in children
Mycophenolate mofetil versus cyclophosphamide plus in patients with connective tissue disease-associated interstitial lung disease: Efficacy and safety analysis
Study of connective tissue disease-associated pulmonary hypertension
Learnings from clinical trials in patients with connective tissue disease-associated interstitial lung disease
Vascular endothelial growth factor in hypersensitivity pneumonitis and connective tissue disease-associated interstitial lung disease
Correction: Learnings from clinical trials in patients with connective tissue disease‑associated interstitial lung disease
Quantitative evaluation of disease severity in connective tissue disease-associated interstitial lung disease by dual-energy computed tomography
Can transbronchial lung cryobiopsy benefit adaptive treatment strategies in connective tissue disease-associated interstitial lung disease?
Azathioprine in connective tissue disease-associated interstitial lung disease : data from a retrospective single centre study
Usefulness of lung ultrasound B-lines in connective tissue disease-associated interstitial lung disease: a literature review
Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study
Autoimmune Disease-Associated Hypertension
Connective tissue disease-associated lung disease in children
Mycophenolate mofetil versus cyclophosphamide plus in patients with connective tissue disease-associated interstitial lung disease: Efficacy and safety analysis
Study of connective tissue disease-associated pulmonary hypertension
Learnings from clinical trials in patients with connective tissue disease-associated interstitial lung disease
Vascular endothelial growth factor in hypersensitivity pneumonitis and connective tissue disease-associated interstitial lung disease
Correction: Learnings from clinical trials in patients with connective tissue disease‑associated interstitial lung disease
Quantitative evaluation of disease severity in connective tissue disease-associated interstitial lung disease by dual-energy computed tomography
Can transbronchial lung cryobiopsy benefit adaptive treatment strategies in connective tissue disease-associated interstitial lung disease?
Azathioprine in connective tissue disease-associated interstitial lung disease : data from a retrospective single centre study
Usefulness of lung ultrasound B-lines in connective tissue disease-associated interstitial lung disease: a literature review
Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study